Late Breaking Clinical Trials 1 PCI, FFR and cost

[LB1-2] Impact of dual antiplatelet therapy with Japanese adjusted-dose prasugrel on mid-term vascular response after everolimus-eluting stent implantation

^○Toba Takayoshi¹, Shinke Toshiro^1,2, Otake Hiromasa¹, Sugizaki Yoichiro¹, Takeshige Ryo¹, Onishi Hiroyuki¹, Nagasawa Akira¹, Tsukiyama Yoshiro¹, Yanaka Kenichi¹, Nagano Yuichiro¹, Yamamoto Hiroyuki¹, Kawamori Hiroyuki¹, Matsuura Akira³, Ishihara Takayuki⁴, Matsumoto Daisuke⁵, Igarashi Nobuaki⁶, Hayashi Takatoshi⁷, Yasaka Yoshinori⁸, Kadotani Makoto⁹, Fujii Takashi¹⁰, Shite Junya¹¹, Okada Masaharu¹², Sakakibara Takashi¹³, Hirata Ken-ichi¹ (1.Kobe University Graduate School of Medicine, Kobe, Japan, 2.Showa University School of Medicine, Tokyo, Japan, 3.Akashi Medical Center, Akashi, Japan, 4.Kansai Rosai Hospital, Amagasaki, Japan, 5.Yodogawa Christian Hospital, Osaka, Japan, 6.Japanese Red Cross Kobe Hospital, Kobe, Japan, 7.Prefectural Awaji Medical Center, Awaji, Japan, 8.Hyogo Brain and Heart Center, Himeji, Japan, 9.Kakogawa City Hospital Organization, Kakogawa, Japan, 10.Ako City Hospital, Ako, Japan, 11.Saiseikai Nakatsu Hospital, Osaka, Japan, 12.Shiga General Hospital, Moriyama, Japan, 13.Nagoya Kyoritsu Hospital, Nagoya, Japan)

同通あり